Edition:
United Kingdom

BiondVax Pharmaceuticals Ltd (BVXV.OQ)

BVXV.OQ on NASDAQ Stock Exchange Capital Market

5.80USD
9:00pm BST
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$5.80
Open
$5.79
Day's High
$5.80
Day's Low
$5.79
Volume
5,581
Avg. Vol
1,841
52-wk High
$7.26
52-wk Low
$3.87

Latest Key Developments (Source: Significant Developments)

Biondvax Pharmaceuticals Ltd Reports Qtrly Loss Per Share of NIS 0.01 ‍​
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Biondvax Pharmaceuticals Ltd ::BIONDVAX PHARMACEUTICALS LTD - QTRLY LOSS PER SHARE NIS 0.01 ‍​.  Full Article

BiondVax and NIH sign clinical trial agreement for phase 2 trial for universal flu vaccine
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Biondvax Pharmaceuticals Ltd :BiondVax and NIH sign clinical trial agreement for a phase 2 trial in the U.S. with BiondVax's universal flu vaccine.BiondVax Pharmaceuticals - ‍NIAID is submitting IND to FDA, participant recruitment anticipated to begin after end of 2017/18 flu season​.  Full Article

Ibex Investors reports 5.5 pct passive stake in BiondVax Pharma
Friday, 22 Sep 2017 

Sept 22 (Reuters) - Ibex Investors LLC:Ibex Investors LLC reports 5.5 percent passive stake in BiondVax Pharmaceuticals Ltd as of Sept 14, 2017 - SEC filing.  Full Article

BiondVax announces public offering of American Depositary Shares
Wednesday, 13 Sep 2017 

Sept 13 (Reuters) - BiondVax Pharmaceuticals Ltd :BiondVax announces public offering of American Depositary Shares.BiondVax Pharmaceuticals Ltd - ‍intends to offer for sale ADS each representing 40 of its ordinary shares which are listed on Tel Aviv stock exchange​.  Full Article

Dual-listed BiondVax to voluntarily delist from Tel Aviv Stock Exchange
Thursday, 31 Aug 2017 

Aug 31 (Reuters) - BiondVax Pharmaceuticals Ltd :Dual-listed BiondVax to voluntarily delist from Tel Aviv Stock Exchange.BiondVax Pharmaceuticals Ltd - ‍Board has decided to voluntarily delist from Tel Aviv Stock Exchange while maintaining a continued listing on Nasdaq​.BiondVax Pharmaceuticals Ltd - Has formed a committee to identify a new chair of board.BiondVax Pharmaceuticals Ltd - ‍Avner Rotman will continue to serve as chairman until a suitable replacement is identified​.‍Delisting process of BiondVax's shares from trading on TASE will take place by end of 2017​.  Full Article

No consensus analysis data available.